|
|
|
2395 SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.
|
|
| 09/16/2026 08:45 |
SNBL's Greenhouse Gas Emissions Reduction Targets Validated by the Science Based Targets initiative (SBTi) |
| 08/05/2026 17:55 |
(Correction and Correction of Numerical Data) Consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP) |
| 08/05/2026 11:30 |
Notice Concerning Revisions of Consolidated Earnings Forecasts for the First Six Months of the Fiscal Year Ending March 31, 2027 |
| 08/05/2026 11:30 |
Consolidated Financial Results for the Three Months of the Fiscal Year Ending March 31, 2027 (Under Japanese GAAP) |
| 08/05/2026 11:30 |
Presentation materials on Financial Results for the First Three Months of the Fiscal Year ending March 31, 2027 |
| 06/26/2026 15:17 |
Corproate Governance Report |
| 06/12/2026 13:00 |
SNBL Receives Full Reaccreditation from AAALAC International |
| 06/06/2026 08:00 |
Notice of Convocation of the 53rd Annual General Meeting of Shareholders |
| 05/29/2026 11:30 |
Notice Regarding Distribution of Year-end Dividends from Retained Earnings |
| 05/11/2026 11:30 |
Presentation Materials for the Fiscal Year Ended March 31, 2026 |
| 05/11/2026 11:30 |
Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 (Under Japanese GAAP) |
| 05/11/2026 11:30 |
Update on Business Development of Atzumi(dihydroergotamine) nasal powder at Satsuma Pharmaceuticals, Inc. |
| 04/30/2026 15:30 |
Notice Concerning Partial Amendments to the Articles of Incorporation |
| 04/30/2026 15:30 |
Notice Concerning Change of Representatives and Assignments of Executive Members |
| 02/06/2026 11:30 |
Presentation Materials on Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2026 |
| 02/06/2026 11:30 |
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP) |
| 02/06/2026 11:30 |
Notice Concerning Revisions to Full-Year Consolidated Financial Forecasts for the Fiscal Year Ending March 31, 2026 |
| 12/27/2025 00:30 |
SNBL Integrated Report 2025 part2 |
| 12/27/2025 00:30 |
SNBL Integrated Report 2025 part1 |
| 12/27/2025 00:30 |
SNBL ESG Data Book2025 |
| 12/26/2025 11:15 |
Corporate Governance Report |
| 11/07/2025 11:30 |
Presentation Materials for the First Six Months of the Fiscal Year Ending March 31, 2026 |
| 11/07/2025 11:30 |
Notice Regarding Differences between Consolidated Financial Forecasts and Actual Results for the Six Months Ended September 30, 2025 |
| 11/07/2025 11:30 |
Notice Regarding Distribution ofInterim Dividends from Retained Earnings |
| 11/07/2025 11:30 |
Consolidated Financial Results for the Six Months Ended September 30, 2025 (Under Japanese GAAP) |
|
